Myocardial Solutions
Private Company
Total funding raised: $3.5M
Overview
Myocardial Solutions, founded in 2012, has developed MyoStrain®, a first-of-its-kind cardiac MRI software platform. The technology quantifies segmental heart muscle function to detect early, asymptomatic cardiac dysfunction, aiming to shift care towards proactive prevention. The company targets a significant market opportunity in heart failure and at-risk patient management by providing novel clinical informatics to physicians. It operates as a private, commercial-stage diagnostics company with a services-oriented business model.
Technology Platform
MyoStrain®: A proprietary cardiac MRI software platform that quantifies segmental myocardial strain across 48 heart segments in a 10-minute analysis, generating a MyoHealth® risk score for early detection of cardiac dysfunction.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes in the cardiac imaging analysis software space. Potential competitors include large medtech companies with ultrasound/MRI analysis suites (e.g., GE HealthCare, Siemens Healthineers) and specialized software firms focusing on echocardiography strain or MRI post-processing. MyoStrain's differentiation is its specific focus on rapid, segmental MRI strain quantification for early detection.